3D QSAR Studies of 1,3,4-oxadiazole derivatives as antimycobacterial agents

Author(s):
Krishna Kant JhaKrishna Kant Jha1,*, Abdul SamadAbdul Samad2, Yatendra KumarYatendra Kumar3, Mohd ShaharyarMohd Shaharyar4, RatanLal KhosaRatanLal Khosa5, Jainendra JainJainendra Jain6, Sandeep BansalSandeep Bansal5
1Department of Pharmaceutical Technology, MIET, Meerut. (U.P.) India
2D.J. College of Pharmacy Modinagar, Ghaziabad, (U.P.) India
3I.T.S. Paramedical College, Muradnagar, Ghaziabad, (U.P.) India
4Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
5B.I.T Meerut, (U.P.) India
6Department of Pharmaceutical Technology, MIET, Meerut, (U.P.) India

IJ Pharmaceutical Research:Vol. 8, issue 3; 163-167
Published online:Nov 20, 2010
Article type:Research Article
Received:May 01, 2008
Accepted:Oct 01, 2008
How to Cite:Jha KK, Samad A, Kumar Y, Shaharyar M, Khosa R, et al. 3D QSAR Studies of 1,3,4-oxadiazole derivatives as antimycobacterial agents. Iran J Pharm Res. 2022;8(3):e128633. doi: https://doi.org/10.22037/ijpr.2010.806

Abstract


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles